Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment

被引:112
作者
Bayer-Carter, Jennifer L. [4 ]
Green, Pattie S. [5 ]
Montine, Thomas J. [6 ]
VanFossen, Brian [4 ]
Baker, Laura D. [4 ]
Watson, Stennis [4 ]
Bonner, Laura M. [4 ]
Callaghan, Maureen
Leverenz, James B. [2 ,7 ]
Walter, Brooke K. [1 ,7 ]
Tsai, Elaine [5 ]
Plymate, Stephen R. [5 ]
Postupna, Nadia [6 ]
Wilkinson, Charles W. [4 ]
Zhang, Jing [6 ]
Lampe, Johanna [8 ]
Kahn, Steven E. [3 ,5 ]
Craft, Suzanne [4 ]
机构
[1] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Dept Neurol, Seattle, WA 98108 USA
[2] Vet Affairs Puget Sound Hlth Care Syst, Parkinsons Dis Res Educ & Clin Ctr, Seattle, WA 98108 USA
[3] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA 98108 USA
[4] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[5] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[6] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[7] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
[8] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
LOW-DENSITY-LIPOPROTEIN; ALZHEIMERS-DISEASE; A-BETA; INSULIN-RESISTANCE; MOUSE MODEL; MEDITERRANEAN DIET; BRAIN; PLASMA; DEMENTIA; RISK;
D O I
10.1001/archneurol.2011.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To compare the effects of a 4-week high-saturated fat/high-glycemic index (HIGH) diet with a low-saturated fat/low-glycemic index (LOW) diet on insulin and lipid metabolism, cerebrospinal fluid (CSF) markers of Alzheimer disease, and cognition for healthy adults and adults with amnestic mild cognitive impairment (aMCI). Design: Randomized controlled trial. Setting: Veterans Affairs Medical Center clinical research unit. Participants: Forty-nine older adults (20 healthy adults with a mean [SD] age of 69.3 [7.4] years and 29 adults with aMCI with a mean [SD] age of 67.6 [6.8] years). Intervention: Participants received the HIGH diet (fat, 45% [saturated fat, >25%]; carbohydrates, 35%-40% [glycemic index, >70]; and protein, 15%-20%) or the LOW diet (fat, 25%; [saturated fat, <7%]; carbohydrates, 55%-60% [glycemic index, <55]; and protein, 15%-20%) for 4 weeks. Cognitive tests, an oral glucose tolerance test, and lumbar puncture were conducted at baseline and during the fourth week of the diet. Main Outcome Measures: The CSF concentrations of beta-amyloid (A beta 42 and A beta 40), tau protein, insulin, F2-isoprostanes, and apolipoprotein E, plasma lipids and insulin, and measures of cognition. Results: For the aMCI group, the LOW diet increased CSF A beta 42 concentrations, contrary to the pathologic pattern of lowered CSF A beta 42 typically observed in Alzheimer disease. The LOW diet had the opposite effect for healthy adults, ie, decreasing CSF A beta 42, whereas the HIGH diet increased CSF A beta 42. The CSF apolipoprotein E concentration was increased by the LOW diet and decreased by the HIGH diet for both groups. For the aMCI group, the CSF insulin concentration increased with the LOW diet, but the HIGH diet lowered the CSF insulin concentration for healthy adults. The HIGH diet increased and the LOW diet decreased plasma lipids, insulin, and CSF F2-isoprostane concentrations. Delayed visual memory improved for both groups after completion of 4 weeks of the LOW diet. Conclusion: Our results suggest that diet may be a powerful environmental factor that modulates Alzheimer disease risk through its effects on central nervous system concentrations of A beta 42, lipoproteins, oxidative stress, and insulin.
引用
收藏
页码:743 / 752
页数:10
相关论文
共 59 条
[1]   Effects of Aerobic Exercise on Mild Cognitive Impairment A Controlled Trial [J].
Baker, Laura D. ;
Frank, Laura L. ;
Foster-Schubert, Karen ;
Green, Pattie S. ;
Wilkinson, Charles W. ;
McTiernan, Anne ;
Plymate, Stephen R. ;
Fishel, Mark A. ;
Watson, G. Stennis ;
Cholerton, Brenna A. ;
Duncan, Glen E. ;
Mehta, Pankaj D. ;
Craft, Suzanne .
ARCHIVES OF NEUROLOGY, 2010, 67 (01) :71-79
[2]   Transport of insulin across the blood-brain barrier: Saturability at euglycemic doses of insulin [J].
Banks, WA ;
Jaspan, JB ;
Huang, WT ;
Kastin, AJ .
PEPTIDES, 1997, 18 (09) :1423-1429
[3]   Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis [J].
Benedict, RHB .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2005, 11 (06) :727-736
[4]   Plasma β-Amyloid and Cognitive Decline [J].
Cosentino, Stephanie A. ;
Stern, Yaakov ;
Sokolov, Elisaveta ;
Scarmeas, Nikolaos ;
Manly, Jennifer J. ;
Tang, Ming Xin ;
Schupf, Nicole ;
Mayeux, Richard P. .
ARCHIVES OF NEUROLOGY, 2010, 67 (12) :1485-1490
[5]   Memory improvement following induced hyperinsulinemia in Alzheimer's disease [J].
Craft, S ;
Newcomer, J ;
Kanne, S ;
DagogoJack, S ;
Cryer, P ;
Sheline, Y ;
Luby, J ;
DagogoJack, A ;
Alderson, A .
NEUROBIOLOGY OF AGING, 1996, 17 (01) :123-130
[6]   Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease - Relationship to severity of dementia and apolipoprotein E genotype [J].
Craft, S ;
Peskind, E ;
Schwartz, MW ;
Schellenberg, GD ;
Raskind, M ;
Porte, D .
NEUROLOGY, 1998, 50 (01) :164-168
[7]   The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia Two Roads Converged [J].
Craft, Suzanne .
ARCHIVES OF NEUROLOGY, 2009, 66 (03) :300-305
[8]   Fish, docosahexaenoic acid and Alzheimer's disease [J].
Cunnane, S. C. ;
Plourde, M. ;
Pifferi, F. ;
Begin, M. ;
Feart, C. ;
Barberger-Gateau, P. .
PROGRESS IN LIPID RESEARCH, 2009, 48 (05) :239-256
[9]   Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers [J].
De Felice, Fernanda G. ;
Vieira, Marcelo N. N. ;
Bomfim, Theresa R. ;
Decker, Helena ;
Velasco, Pauline T. ;
Lambert, Mary P. ;
Viola, Kirsten L. ;
Zhao, Wei-Qin ;
Ferreira, Sergio T. ;
Klein, William L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (06) :1971-1976
[10]   Plaque-associated disruption of CSF and plasma amyloid-β (Aβ) equilibrium in a mouse model of Alzheimer's disease [J].
DeMattos, RB ;
Bales, KR ;
Parsadanian, M ;
O'Dell, MA ;
Foss, EM ;
Paul, SM ;
Holtzman, DM .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (02) :229-236